Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Summary

RATIONALE: Monoclonal antibodies, such as cetuximab, can block abnormal cell growth in different ways. Some block the ability of abnormal cells to grow and spread. Others find abnormal cells and help kill them or carry cell-killing substances to them. PURPOSE: This randomized phase II trial is studying how well cetuximab works in treating patients with precancerous lesions of the upper aerodigestive tract.

Timeline

Start

2007-05

Primary completion

2011-12

Completion

2011-12

Drugs

Indications